Lahey Clinic tests sample control system
Drugsampling.com, a computer controlled system that monitors the distribution of drug samples, is being tested in Boston's Lahey Clinic.
Drugsampling.com, a computer controlled system that monitors the distribution of drug samples, is being tested in Boston's Lahey Clinic.
"Insufficient control [of drug samples] can endanger patients and staff and clearly violates accreditation standards and regulatory statutes," said Ernie Anderson, director of pharmacy at Lahey Clinic. "It also contributes to higher drug costs and makes it difficult for pharmaceutical companies to obtain credible sampling data."
The Drugsampling.com system, which was developed by the Lahey Clinic with the help of ADDS Inc., North Billerica, MA, includes computer-controlled dispensing cabinets that hold a wide range of samples. The cabinets can only be opened by authorized medical staff who are identified through fingerprint-recognition technology.
Once opened, the cabinet contains a touch screen computer that enables physicians to input their name, patient name and drug to be sampled. The system then prints out educational material and labels for the patient in accordance with all Joint Commission on Accreditation of Healthcare Organizations standards while documenting transactions completely.
Currently, Lahey Clinic has the new systems working with 12 clinics and plans to add 12 more before expanding to 44 regional clinics. PR
Reshema Kemps-Polanco: Taking Risks for Greater Reward
May 14th 2025Reshema Kemps-Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of the Year, uses the lessons she learned from her family to bring out the best in her teams.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Novo Nordisk’s Sogroya Demonstrates Efficacy in Children with Growth Disorders
May 14th 2025Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.
